Worldwide Infertility Treatment Industry to 2026 – Rise in Unemployment Amidst Economic Fallout from COVID-19 Push Couples to Consider Delaying Parenthood Plans – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Infertility Treatment – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.
Amid the COVID-19 crisis, the global market for Infertility Treatment estimated at US$1.5 Billion in the year 2020, is projected to reach a revised size of US$2.1 Billion by 2026, growing at a CAGR of 6.7% over the analysis period.
Equipment, one of the segments analyzed in the report, is projected to grow at a 6.6% CAGR to reach US$1 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Media & Consumables segment is readjusted to a revised 7.2% CAGR for the next 7-year period. This segment currently accounts for a 36.4% share of the global Infertility Treatment market.
The U.S. Market is Estimated at $340.6 Million in 2021, While China is Forecast to Reach $462.7 Million by 2026
The Infertility Treatment market in the U.S. is estimated at US$340.6 Million in the year 2021. The country currently accounts for a 22.64% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$462.7 Million in the year 2026 trailing a CAGR of 8.1% through the analysis period.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.5% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6% CAGR while Rest of European market (as defined in the study) will reach US$502.2 Million by the end of the analysis period. Developing countries are augmenting research in the areas of infertility, as the infertility burden is highest in developing regions.
Accessories Segment to Reach $387.9 Million by 2026
In the global Accessories segment, USA, Canada, Japan, China and Europe will drive the 5.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$220.3 Million in the year 2020 will reach a projected size of US$323.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$47.5 Million by the year 2026, while Latin America will expand at a 6.2% CAGR through the analysis period.
Select Competitors (Total 67 Featured) –
- Cook Group Incorporated
- CooperSurgical Fertility & Genomic Solutions
- Esco Micro Pte. Ltd
- Ferring B.V.
- FUJIFILM Irvine Scientific
- Genea Limited
- Hamilton Thorne, Inc
- Ihmedical A/S
- INVO Bioscience
- IVFTech Aps
- Kitazato Corporation
- LABOTECT GMBH
- Medgyn Products, Inc
- Merck KGaA
- Rocket Medical PLC
- Somatex Medical Technologies GmbH
- Thermo Fisher Scientific
- Vitrolife AB
- ZEISS International
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Infertility Treatment – Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Infertility Emerges Into a Global Health Issue
- How Are Total Fertility Rates Calculated & What They Really mean?
- Indications that Fertility Levels Are Continuing to Dip
- Age, a Key Determinant of Fertility
- COVID-19 Pandemic Disrupts Routine Healthcare, Elicits US$89.5 Million Losses in Infertility Treatment Revenues
- How the COVID-19 Pandemic Destroyed the Global Economy
- COVID-19 Leaves the World in Shambles & Industries and Markets Upended: World Economic Growth Projections (Real GDP, Annual % Change) for 2019, 2020 & 2021
- Amid This Public Health Crisis of Unimagined Magnitude, Non-COVID-19 Healthcare Faces the Brunt of Disruptions
- COVID-19 Impact on Healthcare Can be See in the Decline in Number of Non-Essential Surgeries: Annual General Surgeries Performed Worldwide (In Million)
- Rise in Unemployment Amidst Economic Fallout from Covid-19 Push Couples to Consider Delaying Parenthood Plans
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Global Market Outlook 2020 & Beyond
- A Peek Into Regional Dynamics
- An Analysis of Growth Prospects in the Artificial Insemination Market
- Infertility Treatment Options Expands to Include Surrogate Motherhood
- Surrogacy: Types, Process & Cost
- Surrogacy Fertility Tourism
- Ethical & Legal Dilemmas
- Mushrooming of Fertility Clinics to Benefit Market Growth
- Private Investments in Fertility Clinic Chains Increases
- Infertility Clinics Adopt Automation Technologies to Enhance Effectiveness of In-Vitro Fertilization Procedures
- With Obesity Impairing Fertility, Rising Obesity Rates Are Pushing UP Demand for Fertility Treatment
- Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
- Endometriosis is One of the Most Common Causes of Infertility
- Supported by Myriad Factors, IVF Witnesses the Highest Growth
- Technology Innovation, Research & Equipment Automation Gain Momentum
- Fertility Medical Tourism Continues to Rise Amid Controversies
- Spain, the Preferred Country for Fertility Tourism
- Changing Laws Bring Other Countries Into the Spotlight
- Male Infertility, A Traditionally Under Researched Area Gains Attention
- TEX101 as Potential Biomarker of Male Infertility
- Home Based Semen Analysis Gains in Prominence
- Global Innovations in Fertility Treatments Crucial for Continued Growth of the Market
- Novel Techniques of Sperm Selection
- Advancements in Chromosome Testing
- Digital Technologies Like Artificial Intelligence Come to the Aid for Improving Success Rates
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/p2pzwh
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
